Daniel Lochner | CFO |
Jeffrey Nau | President and CEO |
John Snisarenko | Chief Commercial Officer |
Anupam Rama | JPMorgan |
Tara Bancroft | Piper Sandler |
Ken Cacciatore | Cowen & Co. |
Patrick Dolezal | LifeSci Capital |
Good evening and welcome to Oyster Point Pharma’s Fourth Quarter 2020 Earnings Conference Call. My name is Josh, and I’ll be your operator today. After the company’s formal remarks, there will be question-and-answer session. At this time, I would like to turn the call over to Mr. Daniel Lochner, Oyster Point Pharma’s, Chief Financial Officer.